Neuropathology and genetics of cerebroretinal vasculopathies

Grant R Kolar1, Parul H Kothari, Negar Khanlou

  • 1Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO.

Insights

Cerebroretinal vasculopathy (CRV) and related disorders are caused by TREX1 gene mutations, leading to systemic vasculopathy with neurological and ophthalmologic symptoms. These autosomal-dominant conditions typically progress over five years, resulting in death from neurological decline.

Area of Science:

  • Genetics
  • Neurology
  • Ophthalmology

Background:

  • Cerebroretinal vasculopathy (CRV) and related disorders (HERNS, HVR, HSA, collectively RVCL) are severe autosomal-dominant conditions.
  • These diseases manifest with neurological and ophthalmologic symptoms in early to middle age.

Purpose of the Study:

  • To investigate the genetic basis and pathological features of CRV and related disorders.
  • To understand the mechanism linking TREX1 mutations to systemic vasculopathy.

Main Methods:

  • Genetic analysis focusing on mutations in the TREX1 gene.
  • Neuropathological examination of affected individuals.
  • Ultrastructural studies of blood vessel walls.

Main Results:

  • Frameshift mutations in the carboxyl-terminus of the TREX1 gene are identified as the cause.
  • The condition results in systemic vasculopathy with a characteristic 5-year course leading to death.
  • Neuropathology reveals fibrinoid vascular necrosis, white matter ischemia, and dystrophic calcifications.
  • Ultrastructural findings include unusual multilaminated basement membranes in vessel walls.

Conclusions:

  • TREX1 mutations are the underlying cause of CRV and related vasculopathies.
  • These genetic defects lead to a progressive and often fatal systemic vascular disease affecting the brain and eyes.